Cargando…

Platelet-rich fibrin (PRF) gel modified by a carbodiimide crosslinker for tissue regeneration

Platelet-rich fibrin (PRF) as a rich source of effective growth factors has been used as a scaffold in tissue regeneration. It is known that PRF exhibits rapid degradability against enzymes, which should be decreased using crosslinking agents to reduce the release rate of growth factors and increase...

Descripción completa

Detalles Bibliográficos
Autores principales: Karimi, Fatemeh, Biazar, Esmaeil, Heidari-Keshel, Saeed, Pourjabbar, Bahareh, Khataminezhad, Mohammad Reza, Shirinbakhsh, Shervin, Zolfaghari-Moghaddam, S. Yasaman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069288/
https://www.ncbi.nlm.nih.gov/pubmed/35527730
http://dx.doi.org/10.1039/d2ra00985d
_version_ 1784700399834365952
author Karimi, Fatemeh
Biazar, Esmaeil
Heidari-Keshel, Saeed
Pourjabbar, Bahareh
Khataminezhad, Mohammad Reza
Shirinbakhsh, Shervin
Zolfaghari-Moghaddam, S. Yasaman
author_facet Karimi, Fatemeh
Biazar, Esmaeil
Heidari-Keshel, Saeed
Pourjabbar, Bahareh
Khataminezhad, Mohammad Reza
Shirinbakhsh, Shervin
Zolfaghari-Moghaddam, S. Yasaman
author_sort Karimi, Fatemeh
collection PubMed
description Platelet-rich fibrin (PRF) as a rich source of effective growth factors has been used as a scaffold in tissue regeneration. It is known that PRF exhibits rapid degradability against enzymes, which should be decreased using crosslinking agents to reduce the release rate of growth factors and increase the effectiveness of tissue regeneration. In this study, a carbodiimide crosslinker with different concentrations (0.01%, 0.05%, 1%, and 2%) was used to modify and improve the properties of PRF gel. The crosslinked gels were evaluated with analyses such as SEM, swelling, degradability, mechanical strength, release test, cytotoxicity, and cell adhesion. The results showed that with increasing crosslinker concentration, the morphology of the fiber structure changes drastically, the swelling rate decreases from 300% (control) to 160% for the crosslinked gel, the degradation time for the control sample increases from 8 days to more than two weeks for the crosslinked gel, and the Young's modulus increases from 0.15 MPa (control) to 0.61 MPa for the crosslinked samples. Growth factors also showed lower release with increasing crosslinking ratio. Cytotoxicity assays demonstrated that by increasing the crosslinker concentration to 1% w/v, no cytotoxicity was observed. Cellular studies with DAPI staining showed that the cells penetrated well into the gels and were well distributed, especially in gels with lower crosslinker concentrations. In addition, the modified PRF gel can be used as a scaffold for tissue regeneration.
format Online
Article
Text
id pubmed-9069288
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-90692882022-05-05 Platelet-rich fibrin (PRF) gel modified by a carbodiimide crosslinker for tissue regeneration Karimi, Fatemeh Biazar, Esmaeil Heidari-Keshel, Saeed Pourjabbar, Bahareh Khataminezhad, Mohammad Reza Shirinbakhsh, Shervin Zolfaghari-Moghaddam, S. Yasaman RSC Adv Chemistry Platelet-rich fibrin (PRF) as a rich source of effective growth factors has been used as a scaffold in tissue regeneration. It is known that PRF exhibits rapid degradability against enzymes, which should be decreased using crosslinking agents to reduce the release rate of growth factors and increase the effectiveness of tissue regeneration. In this study, a carbodiimide crosslinker with different concentrations (0.01%, 0.05%, 1%, and 2%) was used to modify and improve the properties of PRF gel. The crosslinked gels were evaluated with analyses such as SEM, swelling, degradability, mechanical strength, release test, cytotoxicity, and cell adhesion. The results showed that with increasing crosslinker concentration, the morphology of the fiber structure changes drastically, the swelling rate decreases from 300% (control) to 160% for the crosslinked gel, the degradation time for the control sample increases from 8 days to more than two weeks for the crosslinked gel, and the Young's modulus increases from 0.15 MPa (control) to 0.61 MPa for the crosslinked samples. Growth factors also showed lower release with increasing crosslinking ratio. Cytotoxicity assays demonstrated that by increasing the crosslinker concentration to 1% w/v, no cytotoxicity was observed. Cellular studies with DAPI staining showed that the cells penetrated well into the gels and were well distributed, especially in gels with lower crosslinker concentrations. In addition, the modified PRF gel can be used as a scaffold for tissue regeneration. The Royal Society of Chemistry 2022-05-05 /pmc/articles/PMC9069288/ /pubmed/35527730 http://dx.doi.org/10.1039/d2ra00985d Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by/3.0/
spellingShingle Chemistry
Karimi, Fatemeh
Biazar, Esmaeil
Heidari-Keshel, Saeed
Pourjabbar, Bahareh
Khataminezhad, Mohammad Reza
Shirinbakhsh, Shervin
Zolfaghari-Moghaddam, S. Yasaman
Platelet-rich fibrin (PRF) gel modified by a carbodiimide crosslinker for tissue regeneration
title Platelet-rich fibrin (PRF) gel modified by a carbodiimide crosslinker for tissue regeneration
title_full Platelet-rich fibrin (PRF) gel modified by a carbodiimide crosslinker for tissue regeneration
title_fullStr Platelet-rich fibrin (PRF) gel modified by a carbodiimide crosslinker for tissue regeneration
title_full_unstemmed Platelet-rich fibrin (PRF) gel modified by a carbodiimide crosslinker for tissue regeneration
title_short Platelet-rich fibrin (PRF) gel modified by a carbodiimide crosslinker for tissue regeneration
title_sort platelet-rich fibrin (prf) gel modified by a carbodiimide crosslinker for tissue regeneration
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069288/
https://www.ncbi.nlm.nih.gov/pubmed/35527730
http://dx.doi.org/10.1039/d2ra00985d
work_keys_str_mv AT karimifatemeh plateletrichfibrinprfgelmodifiedbyacarbodiimidecrosslinkerfortissueregeneration
AT biazaresmaeil plateletrichfibrinprfgelmodifiedbyacarbodiimidecrosslinkerfortissueregeneration
AT heidarikeshelsaeed plateletrichfibrinprfgelmodifiedbyacarbodiimidecrosslinkerfortissueregeneration
AT pourjabbarbahareh plateletrichfibrinprfgelmodifiedbyacarbodiimidecrosslinkerfortissueregeneration
AT khataminezhadmohammadreza plateletrichfibrinprfgelmodifiedbyacarbodiimidecrosslinkerfortissueregeneration
AT shirinbakhshshervin plateletrichfibrinprfgelmodifiedbyacarbodiimidecrosslinkerfortissueregeneration
AT zolfagharimoghaddamsyasaman plateletrichfibrinprfgelmodifiedbyacarbodiimidecrosslinkerfortissueregeneration